Mailed self-collection HPV tests more than double cervical cancer screening rates, study shows

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among never- and under-screened U.S. women, according to a first-of-its-kind study by researchers at the University of Texas MD Anderson Cancer Center.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup